- august 9th
- Dr. Rigby
- Atlanta, GA
- september 6th
- Dr. Rigby
- Tampa, FL
- september 26th
- Dr. Cohen
- Houston, TX
- october 19th
- Dr. Birnbaum
- Denver, CO
- october 25th
- Dr. Silverman
- Los Angeles, CA
Designed to educate rheumatology professionals including rheumatologists and rheumatology residents and fellows, along with the multidisciplinary team of NPs, PAs, and nurses.
Provided by North American Center for Continuing Medical Education, LLC.
To be eligible for documentation of credit for this live activity, participants must attend the live session and complete the hard-copy or online evaluation form within 2 weeks of the event. Participants who submit a hard-copy evaluation will receive documentation of credit via email within 8 weeks. Individuals who participate in the workshop and submit the evaluation form online at NACCME.com will immediately receive documentation of credit.
For questions regarding this educational activity, please call 609-371-1137.
After completing this activity, participants should be able to:
- Explain the rationale for targeting mediators of signal transduction within the inflammatory pathways of RA
- Outline the therapeutic profiles and potential clinical roles of newer and emerging agents, including JAK inhibitors, within the management of RA
- Utilize standardized assessment tools and data on the latest clinical evidence to inform step-up and therapeutic sequencing decisions
- Implement early and aggressive management strategies that incorporate evidence based guidelines as well as individual patient goals and preferences
Metroplex Clinical Research Center Clinical Professor of Internal Medicine UT Southwestern School of Medicine Director, Rheumatology Division, Presbyterian Hospital
Professor of Medicine and Pathology NYU School of Medicine
New York, New York
Professor of Medicine and Pathology Geisel School of Medicine at Dartmouth Staff Rheumatologist
Lebanon, New Hampshire
Professor of Medicine
Cleveland Clinic Lerner College of Medicine Case Western Reserve University RJ Fasenmyer
Chair of Clinical Immunology Cleveland, Ohio
Theodore F. Classen, DO Chair of Osteopathic Research and Education Vice Chairman
Department of Rheumatic and Immunologic Diseases
Director, Division of Rheumatology
California Pacific Medical Center
Clinical Professor of Medicine
University of California, San Francisco
San Francisco, California
This activity is designed for rheumatologists and rheumatology residents and fellows, along with the multidisciplinary team of NPs, PAs, and nurses.
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 1.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours.
North American Center for Continuing Medical Education complies with the
legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact 609-371-1137.
Provided by North American Center for Continuing Medical Education, LLC
Supported by independent educational grants from Lilly and Pfizer IGLC.
Dates, meetings, and restaurant locations are subject to change.